{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T15:38:32Z","timestamp":1782315512272,"version":"3.54.5"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,12,3]],"date-time":"2021-12-03T00:00:00Z","timestamp":1638489600000},"content-version":"vor","delay-in-days":2,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","award":["HI19C1235"],"award-info":[{"award-number":["HI19C1235"]}],"id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Approximately one-fourth of the global population is latently infected with <jats:italic>Mycobacterium tuberculosis<\/jats:italic>. An understanding of the burden of latent tuberculosis infection (LTBI) among immigrants compared with the general Korean population should be the first step in identifying priority groups for LTBI diagnosis and treatment. The study aimed to compute the age-standardized LTBI prevalence and predictors among immigrants with LTBI in South Korea.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>In 2018, the Korea Disease Control and Prevention Agency implemented a pilot LTBI screening project for immigrants using a chest radiography and the QuantiFERON Gold In-Tube assay. A standardized prevalence ratio (SPR) was computed to compare the LTBI burden in immigrants and the general Korean population.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>During the duration of the project, a total of 8108 immigrants (5134 males and 2974 females) underwent LTBI screening. The SPR of 1.547 (95% confidence interval [CI] 1.468\u20131.629) in males and 1.261 (95% CI 1.177\u20131.349) in females were both higher than the Korean reference population. Furthermore, among the immigrants, those aged\u2009&lt;\u200940\u00a0years and Korean diaspora visa holders had a higher SPR.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>This study found a higher LTBI prevalence among immigrant population in South Korea compared to that in the general Korean population, and the SPR was higher among those aged\u2009&lt;\u200940\u00a0years and the Korean diaspora. The findings can be used as baseline evidence for including immigrants in South Korea in the at-risk group with a priority need for LTBI screening and treatment.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12879-021-06922-x","type":"journal-article","created":{"date-parts":[[2021,12,3]],"date-time":"2021-12-03T06:02:31Z","timestamp":1638511351000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["The burden and predictors of latent tuberculosis infection among immigrants in South Korea: a retrospective cross-sectional study"],"prefix":"10.1186","volume":"21","author":[{"given":"Sarah","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawoon","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongjo","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,12,3]]},"reference":[{"key":"6922_CR1","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1016\/S1473-3099(16)30216-X","volume":"16","author":"H Alsdurf","year":"2016","unstructured":"Alsdurf H, Hill PC, Matteelli A, Getahun H, Menzies D. The cascade of care in diagnosis and treatment of latent tuberculosis infection: a systematic review and meta-analysis. Lancet Infect Dis. 2016;16:1269\u201378.","journal-title":"Lancet Infect Dis"},{"key":"6922_CR2","doi-asserted-by":"publisher","first-page":"e1002152","DOI":"10.1371\/journal.pmed.1002152","volume":"13","author":"RM Houben","year":"2016","unstructured":"Houben RM, Dodd PJ. The global burden of latent tuberculosis infection: a re-estimation using mathematical modelling. PLoS Med. 2016;13:e1002152.","journal-title":"PLoS Med."},{"key":"6922_CR3","doi-asserted-by":"publisher","first-page":"1900655","DOI":"10.1183\/13993003.00655-2019","volume":"54","author":"A Cohen","year":"2019","unstructured":"Cohen A, Mathiasen VD, Sch\u00f6n T, Wejse C. The global prevalence of latent tuberculosis: a systematic review and meta-analysis. Eur Respir J. 2019;54:1900655.","journal-title":"Eur Respir J"},{"key":"6922_CR4","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1001\/jama.2016.11021","volume":"316","author":"HM Blumberg","year":"2016","unstructured":"Blumberg HM, Ernst JD. The challenge of latent TB infection. JAMA. 2016;316:931\u20133.","journal-title":"JAMA"},{"key":"6922_CR5","unstructured":"World Health Organization. Implementing the end TB strategy: the essentials. Geneva, Switzerland: WHO; 2015. Report No.: 9241509937."},{"key":"6922_CR6","volume-title":"Latent tuberculosis infection: updated and consolidated guidelines for programmatic management","author":"World Health Organization","year":"2018","unstructured":"World Health Organization. Latent tuberculosis infection: updated and consolidated guidelines for programmatic management. Geneva: WHO; 2018."},{"key":"6922_CR7","doi-asserted-by":"publisher","first-page":"1801789","DOI":"10.1183\/13993003.01789-2018","volume":"53","author":"L Apriani","year":"2019","unstructured":"Apriani L, McAllister S, Sharples K, Alisjahbana B, Ruslami R, Hill PC, et al. Latent tuberculosis infection in healthcare workers in low-and middle-income countries: an updated systematic review. Eur Respir J. 2019;53:1801789.","journal-title":"Eur Respir J"},{"key":"6922_CR8","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1038\/s41591-020-1076-0","volume":"26","author":"RK Gupta","year":"2020","unstructured":"Gupta RK, Calderwood CJ, Yavlinsky A, Krutikov M, Quartagno M, Aichelburg MC, et al. Discovery and validation of a personalized risk predictor for incident tuberculosis in low transmission settings. Nat Med. 2020;26:1941\u20139.","journal-title":"Nat Med"},{"key":"6922_CR9","volume-title":"Global tuberculosis report 2015","author":"World Health Organization","year":"2015","unstructured":"World Health Organization. Global tuberculosis report 2015. Geneva: WHO; 2015."},{"key":"6922_CR10","volume-title":"WHO consolidated guidelines on tuberculosis: tuberculosis preventive treatment: annex 3: grade evidence-to-decision tables","author":"World Health Organization","year":"2020","unstructured":"World Health Organization. WHO consolidated guidelines on tuberculosis: tuberculosis preventive treatment: annex 3: grade evidence-to-decision tables. Geneva: WHO; 2020."},{"key":"6922_CR11","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1038\/nm0895-815","volume":"1","author":"SM Blower","year":"1995","unstructured":"Blower SM, McLean AR, Porco TC, Small PM, Hopewell PC, Sanchez MA, et al. The intrinsic transmission dynamics of tuberculosis epidemics. Nat Med. 1995;1:815\u201321.","journal-title":"Nat Med"},{"key":"6922_CR12","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s12916-016-0595-5","volume":"14","author":"M Pareek","year":"2016","unstructured":"Pareek M, Greenaway C, Noori T, Munoz J, Zenner D. The impact of migration on tuberculosis epidemiology and control in high-income countries: a review. BMC Med. 2016;14:48.","journal-title":"BMC Med"},{"key":"6922_CR13","volume-title":"European Centre for Disease Prevention and Control\/WHO Regional Office for Europe","author":"World Health Organization","year":"2013","unstructured":"World Health Organization. European Centre for Disease Prevention and Control\/WHO Regional Office for Europe. Geneva: WHO; 2013."},{"key":"6922_CR14","doi-asserted-by":"publisher","first-page":"624","DOI":"10.5588\/ijtld.16.0845","volume":"21","author":"K L\u00f6nnroth","year":"2017","unstructured":"L\u00f6nnroth K, Mor Z, Erkens C, Bruchfeld J, Nathavitharana RR, van der Werf MJ, et al. Tuberculosis in migrants in low-incidence countries: epidemiology and intervention entry points. Int J Tuberc Lung Dis. 2017;21:624\u201337.","journal-title":"Int J Tuberc Lung Dis"},{"key":"6922_CR15","doi-asserted-by":"publisher","first-page":"1800283","DOI":"10.2807\/1560-7917.ES.2018.23.28.1800283","volume":"23","author":"T Panagiotopoulos","year":"2018","unstructured":"Panagiotopoulos T. Screening for infectious diseases in newly arrived migrants in Europe: the context matters. Euro Surveill. 2018;23:1800283.","journal-title":"Euro Surveill"},{"key":"6922_CR16","doi-asserted-by":"publisher","first-page":"504","DOI":"10.5588\/ijtld.17.0679","volume":"22","author":"HJ Hwang","year":"2018","unstructured":"Hwang HJ, Park JH, Nam S, Lee HJ, Kim HJ, Yu S, et al. Characteristics of a large latent tuberculous infection screening programme using QuantiFERON\u00ae-TB Gold in Korea. Int J Tuberc Lung Dis. 2018;22:504\u20139.","journal-title":"Int J Tuberc Lung Dis"},{"key":"6922_CR17","unstructured":"Korea Disease Control and Prevention Agency & The Korean Academy of Tuberculosis and Respiratory Diseases. The Korean Guideline for Tuberculosis. 2017. Report No.: 8968383405."},{"key":"6922_CR18","doi-asserted-by":"publisher","first-page":"56","DOI":"10.4046\/trd.2015.78.2.56","volume":"78","author":"SH Lee","year":"2015","unstructured":"Lee SH. Diagnosis and treatment of latent tuberculosis infection. Tuberc Respir Dis. 2015;78:56\u201363.","journal-title":"Tuberc Respir Dis"},{"key":"6922_CR19","doi-asserted-by":"publisher","first-page":"104","DOI":"10.4046\/trd.2019.0079","volume":"83","author":"HW Kim","year":"2020","unstructured":"Kim HW, Kim JS. One step toward a low tuberculosis-burden country: screening for tuberculosis infection among the immigrants and refugees. Tuberc Respir Dis. 2020;83:104\u20135.","journal-title":"Tuberc Respir Dis"},{"key":"6922_CR20","unstructured":"Lee J, Han H, Chun G, Park M, Choi H, Yu S. Trends of foreign-born TB cases and a pilot project of latent tuberculosis infection (LTBI) screening in Gyeonggi province in Korea, 2018. Public Health Wkly Rep. 2019;12:523\u201327 https:\/\/bit.ly\/3yOYCVo. Accessed 7 Sep 2021)"},{"key":"6922_CR21","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1080\/1369183X.2012.658545","volume":"38","author":"I-J Yoon","year":"2012","unstructured":"Yoon I-J. Migration and the Korean diaspora: a comparative description of five cases. J Ethn Migr Stud. 2012;38:413\u201335.","journal-title":"J Ethn Migr Stud"},{"key":"6922_CR22","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1093\/pubmed\/23.1.40","volume":"23","author":"S Julious","year":"2001","unstructured":"Julious S, Nicholl J, George S. Why do we continue to use standardized mortality ratios for small area comparisons? J Public Health Med. 2001;23:40\u20136.","journal-title":"J Public Health Med"},{"key":"6922_CR23","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1016\/S1473-3099(19)30260-9","volume":"19","author":"LC Berrocal-Almanza","year":"2019","unstructured":"Berrocal-Almanza LC, Harris R, Lalor MK, Muzyamba MC, Were J, O\u2019Connell AM, et al. Effectiveness of pre-entry active tuberculosis and post-entry latent tuberculosis screening in new entrants to the UK: a retrospective, population-based cohort study. Lancet Infect Dis. 2019;19:1191\u2013201.","journal-title":"Lancet Infect Dis"},{"key":"6922_CR24","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1164\/rccm.201905-0969OC","volume":"201","author":"RK Gupta","year":"2020","unstructured":"Gupta RK, Lipman M, Jackson C, Sitch AJ, Southern J, Drobniewski F, et al. Quantitative IFN-\u03b3 release assay and tuberculin skin test results to predict incident tuberculosis. A prospective cohort study. Am J Respir Crit Care Med. 2020;201:984\u201391.","journal-title":"Am J Respir Crit Care Med."},{"key":"6922_CR25","doi-asserted-by":"publisher","first-page":"110160","DOI":"10.1016\/j.jtbi.2020.110160","volume":"489","author":"A Anzai","year":"2020","unstructured":"Anzai A, Kawatsu L, Uchimura K, Nishiura H. Reconstructing the population dynamics of foreign residents in Japan to estimate the prevalence of infection with Mycobacterium tuberculosis. J Theor Biol. 2020;489:110160.","journal-title":"J Theor Biol."},{"key":"6922_CR26","first-page":"17","volume":"23","author":"C Greenaway","year":"2018","unstructured":"Greenaway C, Pareek M, Abou Chakra CN, Walji M, Makarenko I, Alabdulkarim B, et al. The effectiveness and cost-effectiveness of screening for latent tuberculosis among migrants in the EU\/EEA: a systematic review. Euro Surveill. 2018;23:17\u201300543.","journal-title":"Euro Surveill"},{"key":"6922_CR27","doi-asserted-by":"publisher","first-page":"965","DOI":"10.5588\/ijtld.16.0935","volume":"21","author":"D Zenner","year":"2017","unstructured":"Zenner D, Hafezi H, Potter J, Capone S, Matteelli A. Effectiveness and cost-effectiveness of screening migrants for active tuberculosis and latent tuberculous infection. Int J Tuberc Lung Dis. 2017;21:965\u201376.","journal-title":"Int J Tuberc Lung Dis"},{"key":"6922_CR28","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s12879-020-05712-1","volume":"21","author":"L Kawatsu","year":"2021","unstructured":"Kawatsu L, Uchimura K, Ohkado A. Trend and treatment outcomes of latent tuberculosis infection among migrant persons in Japan: retrospective analysis of Japan tuberculosis surveillance data. BMC Infect Dis. 2021;21:42.","journal-title":"BMC Infect Dis"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-021-06922-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-021-06922-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-021-06922-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,3]],"date-time":"2021-12-03T06:03:47Z","timestamp":1638511427000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-021-06922-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["6922"],"URL":"https:\/\/doi.org\/10.1186\/s12879-021-06922-x","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"13 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was granted ethics exemption by the Konyang University Institutional Review Board (KYURIB-2021-06-059). All methods used in the study were carried out in accordance with relevant guidelines and regulations. The need of informed consent was waived by KYUIRB since we used retrospective data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1206"}}